![Luis Luna](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Luis Eduardo Luna is the founder of Trueamaringos, founded in 2020.
Dr. Luna is currently an Advisor at Noetic Psychedelic.
Education history includes a doctorate from the University of Stockholm, conferred in 1989; a graduate degree from the University of Oslo, conferred in 1980; and an undergraduate degree from Madrid University, conferred in 1972.
Aktive Positionen von Luis Luna
| Unternehmen | Position | Beginn |
|---|---|---|
Noetic Psychedelic
 Noetic Psychedelic Investment ManagersFinance Noetic invests in companies located across the globe. The firm targets companies operating in the fields of across health sectors such as emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness. It provides financing for early stage capital requirements. | Berater | - |
Trueamaringos | Gründer | 01.03.2020 |
Ausbildung von Luis Luna
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
31
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
University of Stockholm
 University of Stockholm Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Madrid University
 Madrid University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Noetic Psychedelic
Noetic Psychedelic Investment ManagersFinance Noetic invests in companies located across the globe. The firm targets companies operating in the fields of across health sectors such as emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness. It provides financing for early stage capital requirements. | Finance |
Trueamaringos |
